Please provide your email address to receive an email when new articles are posted on . An artificial intelligence-guided algorithm to identify cardiac amyloidosis received a breakthrough device ...

Anumana Inc. has garnered a U.S. FDA breakthrough device designation for its artificial intelligence (AI)-powered electrocardiogram-based algorithm for early identification of cardiac amyloidosis. The ...

A new deep-learning algorithm can better identify subtle left ventricular (LV) wall geometric measurements on echocardiography than expert physicians, as validated on three international cohorts, a ...

OXFORD, England, Jan. 10, 2024 /PRNewswire/ -- Ultromics, a patient outcomes-focused AI-driven health technology company with roots at the University of Oxford, UK, has entered into an agreement with ...

Please provide your email address to receive an email when new articles are posted on . A new expert consensus decision pathway published by the American College of Cardiology highlights the ...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has signed an exclusive agreement with University of ...